Skip to main content
UTSW Rheum Grand Rounds - IgG4 Dz - Plasmablasts may be a useful biomarker; but is not generally available in clinical l

Dr. John Cush RheumNow

5 years 8 months ago
UTSW Rheum Grand Rounds - IgG4 Dz - Plasmablasts may be a useful biomarker; but is not generally available in clinical labs (must be done on fresh whole blood) @UTSWIMchief https://t.co/GlEKw0KD3O
UTSW Rheum Grand Rounds - IgG4 Dz common lab findings: hypergammaglobulinemia is common but elevated ESR/CRP are not. Mo

Dr. John Cush RheumNow

5 years 8 months ago
UTSW Rheum Grand Rounds - IgG4 Dz common lab findings: hypergammaglobulinemia is common but elevated ESR/CRP are not. Most have elevated IgG4 serum levels @UTSWIMchief https://t.co/wR5FEqZTsX
UTSW Rheum Grand Rounds - IgG4 Dz commonly presents as major salivary and lacrimal gland enlargement, orbital disease,

Dr. John Cush RheumNow

5 years 8 months ago
UTSW Rheum Grand Rounds - IgG4 Dz commonly presents as major salivary and lacrimal gland enlargement, orbital disease, autoimmune pancreatitis, retroperitoneal (mass) fibrosis or tubulointerstitial nephritis. @UTSWIMchief
UTSW Rheum Grand Rounds - IgG4 Dz renal involvement; most common is tubulointerstitial nephritis
@UTSWIMchief https://t.

Dr. John Cush RheumNow

5 years 8 months ago
UTSW Rheum Grand Rounds - IgG4 Dz renal involvement; most common is tubulointerstitial nephritis @UTSWIMchief https://t.co/q8dZbgmvfK
UTSW Rheum Grand Rounds - Dr. Andres Quiceno on "IgG4 related Disease" Histologic criteria req >40% on IgG4/IgG cells

Dr. John Cush RheumNow

5 years 8 months ago
UTSW Rheum Grand Rounds - Dr. Andres Quiceno on "IgG4 related Disease" Histologic criteria req >40% on IgG4/IgG cells @UTSWIMchief https://t.co/2kOioCdFiM
Being "busy" is about priorties and productivity.

Dr. John Cush RheumNow

5 years 8 months ago
Being "busy" is about priorties and productivity.
Inequities in Telemedicine During COVID-19

Health equity in the telehealth age has assumed added importance since the C

Dr. John Cush RheumNow

5 years 8 months ago
Inequities in Telemedicine During COVID-19 Health equity in the telehealth age has assumed added importance since the COVID-19 pandemic began but what if you don't have access to reliable technology? The problem spreads beyond that though. https://t.co/L8nvUbOqHA https://t.co/SZSmerQGEY
QD Clinic - Smoking and RA
JAMA Dermatology has reported on a longitudinal cohort study of 12,319 secukinumab (SEC) treated patients (psoriasis, psoriatic arthritis, or ankylosing spondylitis); no new cases of active tuberculosis (TB) and very few cases of latent tuberculosis infection (LTBI) were found. 
A Medicare claims analysis of rheumatoid arthritis (RA) patients showed that RA-associated interstitial lung disease (RA-ILD) was seen in nearly 5% of patients and was found to increase mortality risks, including respiratory and cancer mortality not explained by other factors.
Osteoporosis in Men - is often unrecognized till they fracture. Risk factors for OP in men:
- Meds: steroids; PPI immu

Dr. John Cush RheumNow

5 years 8 months ago
Osteoporosis in Men - is often unrecognized till they fracture. Risk factors for OP in men: - Meds: steroids; PPI immunosuppressives - Chronic renal disease - Smoking, ^^alcohol - Sedentary lifestyle - Elderly - Family history: Osteoporosis https://t.co/V4P5wey070
ACR Convergence 2020 Fireside Chats – Top presentations in nr-axSpA, AS, axial PsA

Sponsored by Novartis Medical Aff

Dr. John Cush RheumNow

5 years 8 months ago
ACR Convergence 2020 Fireside Chats – Top presentations in nr-axSpA, AS, axial PsA Sponsored by Novartis Medical Affairs Unable to attend all the key sessions at #ACR20? Listen to the experts as they present their views on the top abstracts. https://t.co/r5Cf4WS63s https://t.co/zN99Jo9bO0
QD Clinic - Myalgias & Arthralgias
Results from Cohort Hip & Cohort Knee study (early symptomatic hip OA pts) finds that 1/9 went on to receive hip rep

Dr. John Cush RheumNow

5 years 8 months ago
Results from Cohort Hip & Cohort Knee study (early symptomatic hip OA pts) finds that 1/9 went on to receive hip replacement during the 10-year follow-up. Clinical hip and Xray (ROA) OA increased over 10 yrs - ROA 19% to 49%, and clinical hip OA 27% to 43% https://t.co/AJXlkAxZiF https://t.co/PSY4ueXOsC
Dr Stanley Cohen has written a nice review of VTE with JAK inhibitors, points out that little/no risk during developmen

Dr. John Cush RheumNow

5 years 8 months ago
Dr Stanley Cohen has written a nice review of VTE with JAK inhibitors, points out that little/no risk during developmental trials, is not the same as a low risk seen with long term use in real world patients (older, higher BMI, more activity) https://t.co/0utVMqHdf9
×